What seems to work best for which poor responders and women over 40?

This is one of those areas where we’d hope the empirical literature would be able to tell us what works for whom and under what conditions. But unfortunately poor responders and women over 40 – and particularly poor responders over 40 – are a relatively small group and rather neglected in the research (JMHO). So, […]

Conflicting expert opinions – how do I know who’s right?

So, you finally plucked up the courage to go for a second opinion, and guess what – now you have two or more well-qualified and plausible experts with compelling arguments telling you to do the exact opposite. Who should you trust? Who’s more credible? And, can’t we just rely on the scientific literature to give us the answers? […]

When and how should I seek a second opinion?

Suppose you had a friend who was grappling with a cancer diagnosis and kept wondering whether his/her specialist had really considered all the possible treatment angles that might work. Suppose he or she had been receiving some treatment but there hadn’t really been any sign of progress. What would you advise? Probably a second opinion, right? For some unknown reason, fertility patients seem to struggle with this notion that it’s somehow disloyal to seek a second opinion. Yes, it is awkward. But actually, it’s just good common sense if there’s any little voice inside your head saying “maybe there’s a better way …” If you think you might want to get a second opinion on your case, here’s what to do … […]

New and “untested” treatments

“My doctor talked about the ethics of infertility treatment and how some clinics will try (and charge for) all sorts of unproven treatment where often there was no medical reason for a particular patient to require that unproven treatment.” The unproven treatment issue is a really interesting one because most medical professionals consider “proven” to mean something supported by multiple randomised controlled trials. The problem is that cutting-edge ideas are new and haven’t had the chance to be sufficiently trialled (or, in some cases, don’t lend themselves to such randomised designs for ethical and/or practical reasons). So, should all the new ideas be ignored until they are considered “proven”? […]